Skip to Content

APO 020 (Omeprazole Delayed Release 20 mg)

Pill with imprint APO 020 is Pink / Red, Capsule-shape and has been identified as Omeprazole Delayed Release 20 mg. It is supplied by Apotex Corp..

Omeprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; indigestion (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 020

Omeprazole delayed release 20 mg APO 020
Omeprazole delayed release 20 mg APO 020 Front
Omeprazole delayed release 20 mg APO 020 Back
Omeprazole delayed release 20 mg APO 020
Omeprazole delayed release 20 mg APO 020

Omeprazole Delayed Release

APO 020
20 mg
Pink / Red
18.00 mm
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
magnesium hydroxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone k30
triethyl citrate
ferric oxide red
titanium dioxide
ferrosoferric oxide
isopropyl alcohol
butyl alcohol
potassium hydroxide
propylene glycol
Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
60505-0065 Apotex Corp.
00904-5684 Major Pharmaceuticals
60505-3952 Apotex Corp.
54569-5482 A-S Medication Solutions, LLC (repackager)
55289-0971 PDRX Pharmaceuticals Inc. (repackager)
33261-0087 Aidarex Pharmacuticals, LLC (repackager)
43063-0212 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.